article thumbnail

The power of communication: engaging diverse groups in healthcare

pharmaphorum

Humans are diverse and communications to engage us need to be inclusive. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected. Today, people are culturally, socially, and demographically diverse.

article thumbnail

Digital innovation drives vaccine development

pharmaphorum

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma needs to adapt its communications or be left behind

pharmaphorum

Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Good, empathetic design allows the science to shine.

article thumbnail

Deep Dive: Digital Health 2022

pharmaphorum

Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Company profile: Vinehealth. Create, approve, deploy: supercharging communications with modular content.

article thumbnail

Big Pharma leading in access-to-medicine strategies, shows data

European Pharmaceutical Review

To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. The research showed 83 percent of pharmaceutical companies are putting more strategies in place.

article thumbnail

Patient adherence – the key to restoring trust in pharma

pharmaphorum

Despite this, pharmaceutical companies have not won over public trust. A recent study found that only 48% of participants expressed trust in pharmaceutical companies. This feeling contributes to a deep mistrust in both specific branded medications and the pharmaceutical industry producing those medications.

article thumbnail

To help solve patient distrust in pharma, industry collaboration is key

pharmaphorum

The UK pharma sector should emerge from COVID-19 with a great deal of goodwill in the bank, especially after rapidly developing vaccines that are helping to steer the world out of the pandemic. This momentum with collaboration and partnership, both with other companies within the industry, as well as external bodies, cannot be lost.